These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12746891)

  • 1. Endothelin and endothelin receptor antagonists in systemic rheumatic disease.
    Mayes MD
    Arthritis Rheum; 2003 May; 48(5):1190-9. PubMed ID: 12746891
    [No Abstract]   [Full Text] [Related]  

  • 2. [PAH and many other indications. Old and new endothelin receptor antagonists.].
    Schmitz J; Holzgrabe U
    Pharm Unserer Zeit; 2010 Nov; 39(6):430-5. PubMed ID: 20967930
    [No Abstract]   [Full Text] [Related]  

  • 3. A new era in the management of pulmonary arterial hypertension related to scleroderma: endothelin receptor antagonism.
    Hachulla E; Coghlan JG
    Ann Rheum Dis; 2004 Sep; 63(9):1009-14. PubMed ID: 15308510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Endothelin].
    Maeda S; Miyauchi T; Goto K
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():112-6. PubMed ID: 16895176
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy according to current guidelines. Practical management of pulmonary arterial hypertension.].
    Pabst S; Hammerstingl C; Nickenig G; Skowasch D
    Pharm Unserer Zeit; 2010 Nov; 39(6):448-52. PubMed ID: 20967933
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical features and endothelin receptor antagonist in primary Sjögren's syndrome with pulmonary arterial hypertension.
    Chen CH; Chen HA; Yang KY; Yu WC; Liao HT; Huang DF
    Scand J Rheumatol; 2006; 35(3):245-7. PubMed ID: 16766376
    [No Abstract]   [Full Text] [Related]  

  • 7. [Endothelin receptor antagonist bosentan. Breakthrough in the treatment of pulmonary hypertension].
    MMW Fortschr Med; 2004 Dec; 146(50):72-3. PubMed ID: 15666438
    [No Abstract]   [Full Text] [Related]  

  • 8. Endothelin receptor antagonists for pulmonary arterial hypertension: an overview.
    Raja SG
    Cardiovasc Ther; 2010 Oct; 28(5):e65-71. PubMed ID: 20406243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathophysiological significance of endothelin in pulmonary hypertension].
    Yoshibayashi M
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():644-7. PubMed ID: 15506466
    [No Abstract]   [Full Text] [Related]  

  • 10. Bosentan.
    Mathier MA; Ishizawar D
    Expert Opin Pharmacother; 2010 Apr; 11(6):1023-34. PubMed ID: 20307226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary hypertension associated with connective tissue disease.
    Fagan KA; Badesch DB
    Prog Cardiovasc Dis; 2002; 45(3):225-34. PubMed ID: 12525998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual endothelin receptor antagonism in pulmonary arterial hypertension.
    Pittrow D; Kirch W
    Eur J Clin Invest; 2006 Sep; 36 Suppl 3():v-vi. PubMed ID: 16919003
    [No Abstract]   [Full Text] [Related]  

  • 13. [Endothelin receptor antagonists in pulmonary arterial hypertension].
    Tokgöz HC; Can MM; Kaymaz C
    Anadolu Kardiyol Derg; 2010 Sep; 10 Suppl 2():9-15. PubMed ID: 20819750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bosentan for treatment of heart failure].
    Yoshimoto T; Hirata Y
    Nihon Rinsho; 2007 May; 65 Suppl 5():159-63. PubMed ID: 17571378
    [No Abstract]   [Full Text] [Related]  

  • 15. Endothelin receptor antagonists.
    Motte S; McEntee K; Naeije R
    Pharmacol Ther; 2006 Jun; 110(3):386-414. PubMed ID: 16219361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin and endothelin receptor antagonism in portopulmonary hypertension.
    Neuhofer W; Gülberg V; Gerbes AL
    Eur J Clin Invest; 2006 Sep; 36 Suppl 3():54-61. PubMed ID: 16919012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Endothelin receptor antagonism in routine clinical care].
    Riemekasten G
    Krankenpfl J; 2005; 43(7-10):245. PubMed ID: 16515314
    [No Abstract]   [Full Text] [Related]  

  • 18. Thrombotic microangiopathic nephropathy, pulmonary hypertension and nephromegaly: case report of a patient treated with endothelin receptor antagonist.
    Losito A; Pittavini L; Covarelli C
    Clin Nephrol; 2012 Feb; 77(2):164-70. PubMed ID: 22257549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin as a clinical target in the treatment of systemic hypertension.
    Prasad VS; Palaniswamy C; Frishman WH
    Cardiol Rev; 2009; 17(4):181-91. PubMed ID: 19525680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Young patient with stress dyspnea of uncertain origin. Evaluate for pulmonary hypertension!].
    MMW Fortschr Med; 2002 Oct; 144(42):64. PubMed ID: 12534004
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.